Summary
Updated Aug 30, 2026
Sangeeta N. Bhatia is Director of VERTEX PHARMACEUTICALS INC / MA (VRTX). 3 SEC Form 4 filings on record going back to 2025, most recently on 5 May 2026. Most recent open-market trade: sold $135K of VRTX on 5 May 2026. Lifetime open-market sales: $371K.
Recent Transactions
4Every recent SEC Form 4 transaction Sangeeta N. Bhatia has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Sangeeta N. Bhatia files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeffrey M. Leiden - $60.94M of VRTX open-market activity in the last 12 months
- Amit Sachdev - $28.38M of VRTX open-market activity in the last 12 months
- Reshma Kewalramani - $19.74M of VRTX open-market activity in the last 12 months
- Carmen Bozic - $11.31M of VRTX open-market activity in the last 12 months
- Charles F. Wagner Jr. - $6.38M of VRTX open-market activity in the last 12 months
- Duncan McKechnie - $5.66M of VRTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Sangeeta N. Bhatia?
Sangeeta N. Bhatia is a corporate insider, tracked as Director of VERTEX PHARMACEUTICALS INC / MA (VRTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Sangeeta N. Bhatia last file a Form 4?
The most recent primary Form 4 on record is dated 5 May 2026, one of 3 filings going back to 2025.
Has Sangeeta N. Bhatia been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($371K) across all tracked filings.
Where can I see all of Sangeeta N. Bhatia's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Sangeeta N. Bhatia and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
